Back to Results
First PageMeta Content
Risk / Science / Genetic engineering / Pharmaceutical industry / Pharmacology / Genetically modified organism / Clinical trial / Biosafety / Biosafety Clearing-House / Clinical research / Biology / Research


Overview of procedures for submitting an application for clinical trials with GMO-medicinal products for human and veterinary use in Belgium Version
Add to Reading List

Document Date: 2014-04-29 05:16:05

Open Document

File Size: 247,05 KB

Share Result on Facebook

City

Brussels / /

Company

Health / /

Country

Belgium / /

IndustryTerm

technology demonstration / clinical trial protocol / multidisciplinary / particular protocol / medicinal products / /

MedicalTreatment

gene therapy / /

Organization

Belgian Biosafety Advisory Council / Federal Competent Authority / Federal Agency for Medicines and Health Products / N.Willemarck / B. Van Vaerenbergh / M. Goossens Biosafety and Biotechnology Unit / Biotechnology Unit / Biosafety and Biotechnology Unit / Federal Agency for Medicines / Health Products / /

Person

B. Van Vaerenbergh / /

/

Position

principal investigator to the Ethics Committee / /

Product

GM medication / /

Technology

gene therapy / clinical trial protocol / ISP / recombination / Biotechnology / particular protocol / /

URL

http /

SocialTag